Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12659/AJCR.924476 http://scihub22266oqcxt.onion/10.12659/AJCR.924476 32796809!7447292!32796809     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32796809&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Am+J+Case+Rep 2020 ; 21 (?): e924476 Nephropedia Template TP {{tp|p=32796809|t=2020. Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report |pdf=|usr=}}{{32796809}} gab.com Text Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report JO: Am J Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32796809 #FOAvip BACKGROUND The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. CASE REPORT A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO(2)) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO(2) levels. Short-term corticosteroid therapy was initiated, and SpO(2) and radiographic findings promptly improved without use of antiviral agents. CONCLUSIONS More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia. Twit Text FOAVip Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report ????Am J Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32796809 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32796809 #FOAvip English Wikipedia <ref>{{Cite pmid|32796809}}</ref> Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report #MMPMID32796809 Urano A; Kasai H; Murai Y; Ikeda H; Urushibara T Am J Case Rep 2020[Aug]; 21 (?): e924476 PMID32796809show ga BACKGROUND The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. CASE REPORT A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO(2)) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO(2) levels. Short-term corticosteroid therapy was initiated, and SpO(2) and radiographic findings promptly improved without use of antiviral agents. CONCLUSIONS More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia. |*Betacoronavirus[MESH] |Aged[MESH] |COVID-19[MESH] |Coronavirus Infections/diagnosis/*drug therapy[MESH] |Drug Administration Schedule[MESH] |Glucocorticoids/*administration & dosage[MESH] |Humans[MESH] |Lung/diagnostic imaging[MESH] |Male[MESH] |Methylprednisolone/*administration & dosage[MESH] |Oxygen/blood[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*drug therapy[MESH] |SARS-CoV-2[MESH]Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 P(epmc).pdf DeepDyve Pubget Overpricing